News & Updates
Filter by Specialty:
TB vax primer augments BCG-induced immune response in bladder cancer patients
Initial results of the phase I RUTIVAC-1 study show the potential of two doses of a tuberculosis (TB) vaccine given after surgery but before standard BCG* treatment to boost immunity and reduce the odds of recurrence in patients with non-muscle-invasive bladder cancer (NMIBC).
TB vax primer augments BCG-induced immune response in bladder cancer patients
15 Apr 2025
Adjuvant chemo does not alter QOL trajectory for CRC patients, but functional recovery a challenge
The health-related quality of life (QOL) trajectories for colorectal cancer (CRC) patients are largely similar, regardless of whether they received adjuvant chemotherapy, according to a study from Singapore. However, CRC patients who undergo adjuvant treatments commonly experience difficulties with functional recovery.
Adjuvant chemo does not alter QOL trajectory for CRC patients, but functional recovery a challenge
12 Apr 2025
Is vitiligo as side effect a good sign for cancer patients on immunotherapy?
Vitiligo occurs as a cutaneous immune-related adverse event during immune checkpoint inhibitor (ICI) therapy in most melanoma and nonmelanoma cancer patients with partial or complete response to treatment, according to a systematic review.
